Literature DB >> 11149410

Factors that influence the penetration of methotrexate through solid tissue.

D S Cowan1, I F Tannock.   

Abstract

Limited penetration of anticancer drugs through tumour tissue is an important factor that may limit therapeutic effects against solid tumours. Here we report studies of the penetration of radiolabelled methotrexate through multicellular layers (MCL) of murine EMT-6 and human MCF-7 cells grown on semiporous teflon membranes. The penetration of methotrexate was only about 25% of that through the teflon membrane alone after 6 hr. This was true for all methotrexate concentrations examined from 10 microM to 3 mM. The presence of folic acid at concentrations above 0.1 mM and of acidic conditions decreased the uptake of methotrexate into single cells and enhanced tissue penetration. Hypoxic conditions and the presence of folinic acid (leucovorin) had no effect on penetration or uptake of methotrexate. Our data provide evidence that tissue penetration of methotrexate is through the extracellular space, that its distribution in solid tissue may be limited and that it may be possible to improve its tissue penetration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11149410     DOI: 10.1002/1097-0215(20010101)91:1<120::aid-ijc1021>3.0.co;2-y

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  A microfluidic system for investigation of extravascular transport and cellular uptake of drugs in tumors.

Authors:  Nelita T Elliott; Fan Yuan
Journal:  Biotechnol Bioeng       Date:  2011-12-26       Impact factor: 4.530

Review 2.  Nanomedicine therapeutic approaches to overcome cancer drug resistance.

Authors:  Janet L Markman; Arthur Rekechenetskiy; Eggehard Holler; Julia Y Ljubimova
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

Review 3.  The challenge of drug resistance in cancer treatment: a current overview.

Authors:  Michail Nikolaou; Athanasia Pavlopoulou; Alexandros G Georgakilas; Efthymios Kyrodimos
Journal:  Clin Exp Metastasis       Date:  2018-05-24       Impact factor: 5.150

4.  Effect of ketoprofen and indomethacin on methotrexate pharmacokinetics in mice plasma and tumor tissues.

Authors:  Yasmine M Elmorsi; Sahar M El-Haggar; Osama M Ibrahim; Mokhtar M Mabrouk
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-11-17       Impact factor: 2.441

5.  Motility is critical for effective distribution and accumulation of bacteria in tumor tissue.

Authors:  Bhushan J Toley; Neil S Forbes
Journal:  Integr Biol (Camb)       Date:  2011-12-22       Impact factor: 2.192

Review 6.  Complex effects of tumor microenvironment on the tumor disposition of carrier-mediated agents.

Authors:  Andrew T Lucas; Lauren Sl Price; Allison Schorzman; William C Zamboni
Journal:  Nanomedicine (Lond)       Date:  2017-07-26       Impact factor: 5.307

7.  Evaluation of therapeutics in three-dimensional cell culture systems by MALDI imaging mass spectrometry.

Authors:  Xin Liu; Eric M Weaver; Amanda B Hummon
Journal:  Anal Chem       Date:  2013-06-11       Impact factor: 6.986

8.  Multicellular tumor spheroids for evaluation of cytotoxicity and tumor growth inhibitory effects of nanomedicines in vitro: a comparison of docetaxel-loaded block copolymer micelles and Taxotere®.

Authors:  Andrew S Mikhail; Sina Eetezadi; Christine Allen
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

Review 9.  Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapy.

Authors:  Mohammad Reza Asgharzadeh; Jaleh Barar; Mohammad M Pourseif; Morteza Eskandani; Mojtaba Jafari Niya; Mohammad Reza Mashayekhi; Yadollah Omidi
Journal:  Bioimpacts       Date:  2017-06-07

10.  Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration.

Authors:  C M Lee; I F Tannock
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.